Supplemental Financial Information - Accounts Payable and Accrued Liabilities (Details) - USD ($) $ in Millions |
Mar. 31, 2026 |
Dec. 31, 2025 |
|---|---|---|
| Other Balance Sheet Details [Abstract] | ||
| Sales rebates and reserves | $ 231.3 | $ 226.0 |
| Current income taxes payable | 186.4 | 68.0 |
| Accrued development costs | 110.7 | 101.3 |
| Accrued employee related costs | 81.7 | 128.8 |
| Current branded prescription drug fee | 42.9 | 45.3 |
| Accounts payable and other accrued liabilities | 120.0 | 104.9 |
| Total accounts payable and accrued liabilities | $ 773.0 | $ 674.3 |
| X | ||||||||||
- Definition Accrued Branded Prescription Drug Fee No definition available.
|
| X | ||||||||||
- Definition Accrued Research And Development Expense Current No definition available.
|
| X | ||||||||||
- Definition Other balance sheet details. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer. No definition available.
|
| X | ||||||||||
- Definition Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cumulative provision for contract losses not offset against related costs accumulated on the balance sheet. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|